Form RW WINDTREE THERAPEUTICS
![SEC EDGAR](../../../Content/images/providers/SC.png)
Windtree Therapeutics, Inc. (WINT)
Last windtree therapeutics, inc. earnings: 8/21 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
windtreetx.investorroom.com
Company Research
Source: SEC EDGAR
![SEC EDGAR](../../../Content/images/providers/SC.png)
Impact Snapshot
Event Time:
WINT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WINT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WINT alerts
High impacting Windtree Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
WINT
News
- Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic ShockGlobeNewswire
- Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business UpdatesGlobeNewswire
- Windtree Announces New Additions and Changes to Its Board of DirectorsGlobeNewswire
- Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial DataGlobeNewswire
- Windtree Therapeutics Announces Closing of Financing Through a Private Placement of Series C Preferred Stock [Yahoo! Finance]Yahoo! Finance
WINT
Sec Filings
- 9/4/24 - Form EFFECT
- 9/4/24 - Form EFFECT
- 9/3/24 - Form 424B5
- WINT's page on the SEC website